Literature DB >> 11213741

Congenital nasolacrimal duct obstruction: irrigation or probing?

Y S Kim1, S C Moon, K W Yoo.   

Abstract

The authors investigated the efficacy of antibiotic irrigation as the therapeutic option in congenital nasolacrimal duct obstruction. We retrospectively reviewed the medical record of 76 patients' eyes in whom congenital nasolacrimal duct obstruction had been diagnosed. In 50 of these patients, the colonizing microorganism was identified and, irrigation through canaliculi was performed using antibiotics of suitable sensitivity. Nasolacrimal system probing was performed on 26 patients as the control group. Treatment was regarded successful when over a 4 week period epiphora or mucous discharge disappeared and when saline passed without resistance on irrigation. 96.0% of patients in the irrigation group and 84.6% of patients in probing group were treated successfully. There was no statistical difference in the success rate between the two groups (P = 0.173). The recovery period based on culture results was 3.22 +/- 0.37 months in the group in which microorganisms were isolated and 2.39 +/- 0.35 months in the group in which no organisms were isolated. There were no statistically significant differences in the success rates between the group in which there was growth and the group in which there was no growth (P = 0.1308). Thus a similar result was obtained using nasolacrimal probing and canaliculus antibiotic irrigation in congenital nasolacrimal duct obstruction. Antibiotic irrigation is a safe and simple therapeutic option in congenital nasolacrimal duct obstruction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11213741     DOI: 10.3341/kjo.2000.14.2.90

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  8 in total

1.  Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.

Authors:  Deok Sun Cha; Hwa Lee; Min Soo Park; Jong Mi Lee; Se Hyun Baek
Journal:  Korean J Ophthalmol       Date:  2010-10-05

2.  Value of microbiology study in congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky; Tahir Naeem; Nora Al-Sobaie; Reem Al-Huthail; Hessa Al-Odan; Essam A Osman; Ahmad Mousa
Journal:  Saudi J Ophthalmol       Date:  2012-03-10

3.  The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.

Authors:  Omer Karti; Eyyup Karahan; Durgul Acan; Tuncay Kusbeci
Journal:  Int Ophthalmol       Date:  2016-03-07       Impact factor: 2.031

4.  Clinical Outcome of Probing in Infants with Acute Dacryocystitis - A Prospective Study.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Bibhuti Prasanna Sinha
Journal:  J Clin Diagn Res       Date:  2017-08-01

5.  Success rate of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Semi Perveen; Aalia Rasool Sufi; Sabia Rashid; Afroz Khan
Journal:  J Ophthalmic Vis Res       Date:  2014-01

6.  Tobramycin/dexamethasone eye drops as a better choice for lacrimal duct probing in persistent congenital nasolacrimal duct obstruction: A consort study.

Authors:  Qin Xiang; Dan Hu; Xu Gao
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 7.  Congenital Nasolacrimal Duct Obstruction (CNLDO): A Review.

Authors:  Aldo Vagge; Lorenzo Ferro Desideri; Paolo Nucci; Massimiliano Serafino; Giuseppe Giannaccare; Andrea Lembo; Carlo Enrico Traverso
Journal:  Diseases       Date:  2018-10-22

8.  Lacrimal sac bacteriology and susceptibility pattern in infants with congenital nasolacrimal duct obstruction in the 1st year of life: a cross-sectional study.

Authors:  Xiao-Yu Zheng; Bonnie Nga Kwan Choy; Ming-Ming Zhou; Cai-Ping Shi; Zheng-Yan Zhao
Journal:  BMC Pediatr       Date:  2020-10-06       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.